tiprankstipranks
Biocept (BIOCQ)
OTHER OTC:BIOCQ
Holding BIOCQ?
Track your performance easily

Biocept (BIOCQ) Stock Price & Analysis

1,249 Followers

BIOCQ Stock Chart & Stats


Financials

Annual

Ownership Overview

5.00%95.00%
Insiders
Mutual Funds
5.00% Other Institutional Investors
95.00% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

BIOCQ FAQ

What was Biocept’s price range in the past 12 months?
Biocept lowest stock price was $0.00 and its highest was $0.13 in the past 12 months.
    What is Biocept’s market cap?
    Currently, no data Available
    When is Biocept’s upcoming earnings report date?
    Biocept’s upcoming earnings report date is Aug 12, 2024 which is 132 days ago.
      How were Biocept’s earnings last quarter?
      Currently, no data Available
      Is Biocept overvalued?
      According to Wall Street analysts Biocept’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Biocept pay dividends?
        Biocept does not currently pay dividends.
        What is Biocept’s EPS estimate?
        Biocept’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Biocept have?
        Biocept has 2,626,026 shares outstanding.
          What happened to Biocept’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Biocept?
          Currently, no hedge funds are holding shares in BIOCQ
          ---

          Biocept Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Company Description

          Biocept

          Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          OncoCyte
          VolitionRX
          Myriad Genetics
          Fulgent Genetics
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis